Differential Diagnosis: Chest Pain with Negative Cardiac Workup and Elevated CO₂
In a patient with chest pain, negative cardiac workup, and elevated CO₂ (hypercapnia), the primary differential diagnosis should focus on pulmonary causes—particularly chronic obstructive pulmonary disease (COPD), obesity hypoventilation syndrome, or neuromuscular/chest wall disorders—followed by gastrointestinal and musculoskeletal etiologies.
Algorithmic Approach to Diagnosis
Step 1: Characterize the Hypercapnia Pattern
The presence of elevated CO₂ fundamentally shifts your diagnostic thinking away from acute coronary syndrome toward conditions causing ventilatory failure 1.
Key laboratory assessment:
- Measure serum bicarbonate (total CO₂): A level ≥27 mmol/L suggests chronic hypercapnia with metabolic compensation 2
- Arterial blood gas: Confirms hypercapnia and distinguishes acute vs. chronic respiratory acidosis
- Assess for hypoxemia: Often accompanies hypercapnia due to the alveolar gas equation 3
Step 2: Primary Pulmonary Causes (Most Likely)
COPD with hypercapnic respiratory failure:
- Look for: Low FEV₁, high residual volume, history of smoking, dyspnea 4
- Hypercapnia in COPD relates to poor lung mechanics, high CO₂ production, and reduced ventilatory capability 4
- Critical pitfall: Clinicians often misattribute hypercapnia to cardiac disease when COPD is the actual cause 2
Obesity Hypoventilation Syndrome (OHS):
- Requires: BMI ≥30 kg/m², daytime hypercapnia (PaCO₂ >45 mmHg), and sleep-disordered breathing 2
- Screen with: Serum bicarbonate ≥27 mmol/L (sensitivity for detecting OHS in obese patients with sleep-disordered breathing) 2
- Associated findings: Excessive daytime sleepiness, polycythemia, pulmonary hypertension
Neuromuscular or Chest Wall Disorders:
- Consider: Muscular dystrophy, motor neuron disease, kyphoscoliosis, post-polio syndrome 3
- Key features: Progressive dyspnea, orthopnea, weak cough, skeletal deformities
- Important: These patients can present with hypercapnia before significant locomotor disability develops 3
- Even minor respiratory infections can precipitate acute-on-chronic hypercapnic failure 3
Step 3: Secondary Non-Cardiac Causes
Once cardiac causes are excluded 1, the 2021 AHA/ACC/ASE guidelines direct evaluation toward:
Gastrointestinal causes (10-20% of non-cardiac chest pain):
- Gastroesophageal reflux disease: Burning retrosternal pain, worse after meals or at night, may respond to antacids 1, 5, 6
- Esophageal motility disorders: Achalasia, nutcracker esophagus, diffuse esophageal spasm—present with squeezing pain and dysphagia 1, 6
- Evaluation approach: Trial of acid suppression first; if symptoms persist despite negative upper endoscopy, proceed to esophageal function testing and pH monitoring 1
Musculoskeletal causes (40-50% of non-cardiac chest pain):
- Costochondritis: Most common (42% of cases); pain reproducible by palpation of costochondral joints 7, 5, 6
- Chest wall syndrome: Stinging or pressing pain, often left-sided or retrosternal, chronic (>6 months in 55% of cases) 7
- Physical exam is diagnostic—tenderness to palpation markedly reduces probability of cardiac etiology 1
Pulmonary causes to exclude:
- Pulmonary embolism: Tachycardia, dyspnea, pleuritic pain; use Wells criteria for risk stratification 1, 5
- Pneumonia: Fever, localized pleuritic pain, egophony, dullness to percussion 1
- Pneumothorax: Unilateral absence of breath sounds, pleuritic pain 1
Psychological causes (10% of cases):
- Panic disorder, anxiety, somatoform disorders 8, 6
- Diagnosis of exclusion in appropriate clinical context 1
Critical Clinical Pearls
The hypercapnia component is the key distinguishing feature:
- Hypercapnia does NOT occur with typical musculoskeletal, gastrointestinal, or anxiety-related chest pain
- The combination of chest pain + elevated CO₂ + negative cardiac workup strongly suggests an underlying pulmonary/ventilatory disorder that may be causing both symptoms
Common pitfall to avoid:
- Do not assume the chest pain and hypercapnia are unrelated findings 2. The hypercapnia may be causing dyspnea that the patient describes as "chest pain," or the underlying condition (e.g., COPD, OHS) is causing both manifestations
Immediate management considerations:
- Use controlled oxygen therapy targeting SpO₂ 88-92% in patients at risk of hypercapnia 3, 9
- Over-oxygenation (SpO₂ >92%) occurs in 37% of hypercapnic patients receiving supplemental oxygen and increases mortality risk 9
- Consider non-invasive ventilation (NIV) early in neuromuscular/chest wall disorders—do not wait for acidosis to develop 3
Recommended Diagnostic Sequence
- Arterial blood gas + serum bicarbonate to confirm and characterize hypercapnia
- Pulmonary function tests to identify obstructive or restrictive patterns
- Sleep study if obesity or unexplained hypercapnia suggests OHS 2
- Chest imaging (X-ray or CT) to evaluate for structural lung disease, chest wall abnormalities
- Upper endoscopy or trial of acid suppression if gastrointestinal symptoms predominate 1
- Focused musculoskeletal examination with palpation of chest wall structures 7, 1